MENU
IMAB I-MAB Chart, History Price & Graph
a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
IMAB and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, IMAB has been loosely correlated with SEER. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IMAB jumps, then SEER could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To IMAB | 1D Price Change % | ||
|---|---|---|---|---|
| IMAB | 100% | -7.08% | ||
| SEER - IMAB | 35% Loosely correlated | -0.60% | ||
| AURA - IMAB | 35% Loosely correlated | -7.04% | ||
| RLAY - IMAB | 34% Loosely correlated | -4.71% | ||
| ARQT - IMAB | 34% Loosely correlated | -3.49% | ||
| BEAM - IMAB | 34% Loosely correlated | -8.55% | ||
More | ||||